It's a Type 2 Life
It's a Type 2 Life

San Francisco Bay Area resident Patrick Totty writes about his experiences living with type 2 diabetes

See all posts »

A Rival to Swiss Chocolate?

TEXT SIZE: A A A

Although many people think that type 1 diabetics are the only people who take insulin injections, an estimated 11 million type 2s in Europe and North America are also on insulin therapy.

They deal with many of the same hassles that type 1s do, including having to take multiple daily injections.

No matter how practiced they are, there are still numerous demands imposed by their routine: remembering when to take insulin; checking to see that the insulin is not outdated or has been heat damaged; and making sure the dose is correct.  

There’s also the problem of bad timing or concerns about public exposure. No matter how fluid their movements or how discreet they are, there are just some locations and occasions when injecting insulin isn’t a good idea.

What would be welcome is a simple injection device for type 2s, hidden under clothes, that would quietly deliver insulin at set times.

Well, such a device may be in the offing. A Swiss company, CeQur SA, has completed a clinical study of its PaQ® insulin delivery device and expects to share the test results early next year.

The device, which provides three days of basal insulin delivery, plus on-demand bolus insulin*, consists of a disposable insulin infuser reservoir that’s attached to a reusable insulin monitor.

Researchers at University Hospital Graz in Austria divided the study into three two-week segments: baseline, which established patients’ dosing needs and habits; transition to the PaQ device; and then daily use of the device and the results from it.

If PaQ proves to be a reliable insulin delivery system, it could go a long way toward increasing the number of compliant insulin-using type 2s. Some medical experts estimate that half of all patients who require multiple daily insulin injections deliberately skip doses if injecting themselves disrupts their routines or embarrasses them.

For more information on CeQur and the PaQ system, link here.

*Basal insulin is long-lasting insulin that works over a 24-hour period. Bolus insulin is shorter-lasting, quick-acting insulin that works to counter the high blood sugar spikes that often occur after a person with diabetes has eaten. 

 

 

  • 1

Tags: Food

Was this article helpful? Yes No

Recommended for You

  • Words Not Spoken, Facts Not Presented

    By: Patrick Totty
    Oct 24, 2012

    When it comes to dealing with diabetes, never forget that some of the information we get doesn’t always fully disclose the facts. If that sounds paranoid, I don’t mean to come off that way. But as a former newspaperman, I know how easy it is ...

    Read more »

  • A Diabetic Doctor's Take on Carb Cravings

    By: Patrick Totty
    Oct 15, 2012

    I’ve mentioned Dr. Richard Bernstein here before. Bernstein is the 78-year-old Long Island-based doctor who for years has been a thorn in the side of the American Diabetes Association. That’s because of his advocacy of a low-carb approach to bo...

    Read more »

  • Priscilla's Grits

    By: Patrick Totty
    Oct 10, 2012

    I mentioned recently that my wife and I were taking a trip through the beautiful red rock country of southern Utah. To get there, we drove along back roads through California and central Nevada. One of our stops in Nevada was the hamlet of ...

    Read more »

  • Conflicting Views on Cinnamon for Type 2

    By: Patrick Totty
    Oct 04, 2012

    There’s a story about a monastery in the Dark Ages where the friars are sitting around the dinner table disputing how many teeth are in a horse’s mouth. The elder monks are citing Aristotle for their answer, but there’s an argument over the ...

    Read more »

Advertisement

About the Author

Bay Area resident Patrick Totty was diagnosed with type 2 diabetes in July, 2003.

Recent Blog Posts

Advertisement
Advertisement